CEPTAZ INJECTION - PWS IM IV 1G/VIAL
CEPTAZ INJECTION - PWS IM IV 1G/VIAL
Discontinued
DIN Number
02215012
Drug Class
Human
Market Date
Sep 1, 2001
Company
HC
GlaxoSmithKline Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02215012
AIG Number0116900004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01DD02 CEFTAZIDIME
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
,
Intramuscular
AHFS Classification08:12.06.12
Health Canada Classification
ACTIVE INGREDIENTS (1)
CEFTAZIDIMEActive
Strength: 1 G / VIAL
Monograph: CEFTAZIDIME